Binding parameters of antibodies: pseudo-affinity and other misconceptions M. Jules. Mattes Position Paper 31 December 2004 Pages: 513 - 516
New developments in dendritic cell–based vaccinations: RNA translated into clinics Frank GrünebachMartin R. MüllerPeter Brossart Review 27 January 2005 Pages: 517 - 525
Lack of effective T-lymphocyte response to the PAX3/FKHR translocation area in alveolar rhabdomyosarcoma David A. RodebergRebecca A. NussEsteban Celis Original Article 20 November 2004 Pages: 526 - 534
Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice Robert J. MelderBlaire L. OsbornGilles Gallant Original Article 08 December 2004 Pages: 535 - 547
Secretomers as a new tool for the monitoring of CTL responses Bastien CalmelsStephane PaulBruce Acres Original Article 14 December 2004 Pages: 548 - 556
T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody Szilvia MosolitsKatja MarkovicMahmood Jeddi-Tehrani Original Article 27 November 2004 Pages: 557 - 570
Prevention of de novo prostate cancer by immunization with tumor-derived vaccines Mark A. SuckowWilliam R. WolterMorris Pollard Original Article 01 February 2005 Pages: 571 - 576
What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors S. Farzana HussainYvonne Paterson Symposium Paper 14 January 2005 Pages: 577 - 586
Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory Volker Schirrmacher Review 30 October 2004 Pages: 587 - 598
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario Annalisa AstolfiSimona RollaRaffaele A. Calogero Symposium Paper 03 February 2005 Pages: 599 - 610
Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma Marc BrinkmanJuergen WalterJuergen Hess Symposium Paper 01 February 2005 Pages: 611 - 622